Bristol-Myers: Why I Am Buying More Of This Falling Knife, Yielding 5.84%

PM Images I am not a trader, and I make most of my investment decisions based on a long-term time horizon. I can't time the market, and Bristol-Myers Squibb (NYSE:BMY) is a perfect example of an investment that's continued lower despite my long-term investment thesis. BMY looks like a falling knife, and the cuts are getting deeper and deeper. Over the past year, shares of BMY have declined by -36.24% as they fell from the mid $60s to the low $40s. Nothing about the long-term charts is exciting either, as BM ...